---
title: "First-in-human study of Protaryx transseptal puncture technology completed"
date: "2024-12-11T15:11:58.000Z"
publishedDate: "11 décembre 2024"
summary: "Protaryx Medical has announced the completion of its first-in-human (FIH) study, assessing its advanced transseptal puncture technology. Conducted on 3 December 2024 at Sanatorio Italiano de Asunción (Asunción, Paraguay), the study enrolled five patients under approval from the Research Ethics Committee of the Paraguayan Institute of Social Studies."
importance: ""
sourceUrl: "https://cardiovascularnews.com/first-in-human-study-protaryx/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2024-12-11-first-in-human-study-of-protaryx-transseptal-puncture-technology-completed"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2020/08/Medical-students-1024x768-1.jpeg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/first-in-human-study-protaryx/"
---

![First-in-human study of Protaryx transseptal puncture technology completed](https://cardiovascularnews.com/wp-content/uploads/sites/14/2020/08/Medical-students-1024x768-1.jpeg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/first-in-human-study-protaryx/*

## L’essentiel

Protaryx Medical has announced the completion of its first-in-human (FIH) study, assessing its advanced transseptal puncture technology. Conducted on 3 December 2024 at Sanatorio Italiano de Asunción (Asunción, Paraguay), the study enrolled five patients under approval from the Research Ethics Committee of the Paraguayan Institute of Social Studies.

## Lien source

https://cardiovascularnews.com/first-in-human-study-protaryx/
